Marko Topalovic ^UDM

Marko Topalović, CEO of ArtiQ, leads a medical software company that harnesses artificial intelligence (AI) to enhance the diagnosis, treatment, and monitoring of patients with respiratory diseases. Marko's experience in leading a dynamic team, coupled with his scientific background, drives the development and sale of smart software at ArtiQ. The company, founded in 2019, aims to be a trusted Partners for medical practitioners by leveraging AI for interpreting pulmonary function tests and improving the diagnostic environment for lung diseases. ArtiQ's innovative solutions showcase Marko's commitment to connecting medicine and technology for the betterment of healthcare.